Literature DB >> 7739724

Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.

W A Sheremata, J R Taylor, G W Elgart.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7739724     DOI: 10.1056/NEJM199506083322316

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis.

Authors:  Antonie Giaever Beiske; Kjell-Morten Myhr
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

2.  Necrotising cutaneous lesions as a side effect of glatiramer acetate.

Authors:  Isabel Bosca; Maria Bosca; Antonio Belenguer; Monserrat Evole; Miguel Hernandez; Bonaventura Casanova; Francisco Coret
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

3.  A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.

Authors:  C Albani; G Albani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 4.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

5.  Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.

Authors:  Gita Faghihi; Akram Basiri; Mohsen Pourazizi; Bahareh Abtahi-Naeini; Ali Saffaei
Journal:  J Res Pharm Pract       Date:  2015 Apr-Jun

6.  The role of host soluble inflammatory mediators induced by the BCG vaccine for the initiation of in vitro monocyte apoptosis in healthy Brazilian volunteers.

Authors:  Jessica Lima; Mariana Siqueira; Paulo R Z Antas; Thaíze Pedro; Carlos Ponte; Leandro Peres; Suelen Marinho; Luíz R Castello-Branco
Journal:  J Inflamm (Lond)       Date:  2015-10-29       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.